Tim Butler
Principal Scientist,
Quotient Therapeutics
Tim Butler is a member of the Genomic Sciences team at Quotient Therapeutics, where his work focuses on applying insights from somatic genomics to drug discovery, with particular emphasis on immunology and inflammation, and metabolic diseases. He contributes to efforts combining sequencing, imaging, and spatial insights to uncover disease-relevant biology, identify promising therapeutic targets, and translate human genomic data into new treatment opportunities.
Sessions
-
Drug Target Discovery through Somatic Genomics28-Jan-2027Multi-Omics Stage